Influence of neuroblastoma stage on serum-based detection of MYCN amplification

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 329-331

  Combaret, Valerie ^a   Hogarty, Michael D ^b   London, Wendy B ^c   McGrady, Patrick ^c   Iacono, Isabelle ^a   Brejon, Stephanie ^a   Swerts, Katrien ^d   Noguera, Rosa ^e   Gross, Nicole ^f   Rousseau, Raphael ^g,h,i   Puisieux, Alain ^a,g,i  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY OF VALENCIA   (Spain)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g INSERM   (France)

^h Paediatric Department   (France)

ⁱ UNIVERSITÉ LYON 1   (France)

Author keywords

Circulating DNA; MYCN amplification; Neuroblastoma

Indexed keywords

DNA;

ARTICLE; ASSAY; CANCER STAGING; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA ISOLATION; DNA SEQUENCE; EVALUATION; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; TUMOR GENE; TUMOR VOLUME;

EID: 67651222655     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22009     Document Type: Article

References (12)

1. Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1997;37:646-650.
2. Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-322. (Pubitemid 19216753)
3. Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999;18:65-73. (Pubitemid 29411092)
4. Lo YM. Circulating nucleic acids in plasma and serum: An overview. Ann NYAcad Sci 2001;945:1-7. (Pubitemid 33022426)
5. Combaret V, Bergeron C, Noguera R, et al. Circulating MYCN DNAas a tumor-specific marker in neuroblastoma patients. Cancer Res 2002;62:3646-3648. (Pubitemid 34728840)
6. Combaret V, Audoynaud C, Iacono I, et al. Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma. J Clin Oncol 2005;23:8919-8920. (Pubitemid 46211544)
7. Gotoh T, Hosoi H, Iehara T, et al. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 2005;23: 5205-5210. (Pubitemid 46224030)
8. Rubie H, Hartmann O, Michon J, et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1997;15:1171-1182.
9. Stroun M, Anker P. Nucleic acids spontaneously released by living frog auricles. Biochem J 1972;128:100-101.
10. Anker P, Stroun M, Maurice PA. Spontaneous release of DNA by human blood lymphocytes a shown in an in vitro system. Cancer Res 1975;9:2375-2382.
11. Tamkovich SN, Cherepanova AV, Kolesnikova EV, et al. Circulating DNA and DNase activity in human blood. Ann NY Acad Sci 2006;1075:191-196.
12. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of highrisk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-1173.